Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
Open Access
- 18 June 2010
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 9 (1), 154
- https://doi.org/10.1186/1476-4598-9-154
Abstract
Background Formation of tumour cell aggregation/emboli prolongs the survival of circulating tumour cells in the circulation, enhances their physical trapping in the micro-vasculature and thus increases metastatic spread of the cancer cells to remote sites. Results It shows here that the presence of the galactoside-binding galectin-3, whose concentration is markedly increased in the blood circulation of cancer patients, increases cancer cell homotypic aggregation under anchorage-independent conditions by interaction with the oncofetal Thomsen-Friedenreich carbohydrate (Galβ1,3GalNAcα-, TF) antigen on the cancer-associated transmembrane mucin protein MUC1. The galectin-3-MUC1 interaction induces MUC1 cell surface polarization and exposure of the cell surface adhesion molecules including E-cadherin. The enhanced cancer cell homotypic aggregation by galectin-MUC1 interaction increases the survival of the tumour cells under anchorage-independent conditions by allowing them to avoid initiation of anoikis (suspension-induced apoptosis). Conclusion These results suggest that the interaction between free circulating galectin-3 and cancer-associated MUC1 promotes embolus formation and survival of disseminating tumour cells in the circulation. This provides new information into our understanding of the molecular mechanisms of cancer cell haematogenous dissemination and suggests that targeting the interaction of circulating galectin-3 with MUC1 in the circulation may represent an effective therapeutic approach for preventing metastasis.Keywords
This publication has 41 references indexed in Scilit:
- Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell SurfaceCancer Research, 2009
- Galectin–glycan lattices regulate cell-surface glycoprotein organization and signallingBiochemical Society Transactions, 2008
- Dissecting the metastatic cascadeNature Reviews Cancer, 2004
- MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 InteractionsPublished by Elsevier BV ,2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001
- Circulating Breast Cancer Cells Are Frequently ApoptoticThe American Journal of Pathology, 2001
- Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinomaCancer, 2000
- The Hallmarks of CancerCell, 2000
- A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.Molecular Biology of the Cell, 1996